Genetic sequencing

Global Point of Care (POC) Molecular Diagnostics Market to Reach $5.2 Billion by 2026

Retrieved on: 
Friday, October 8, 2021
Growth, Ambulance, DNA sequencing, Infection, Cancer, POC, Genetic sequencing, Technology, Abbott Laboratories, ISH, CAGR, COVID-19, Microarray, Marketing, Sysmex Corporation, Prevalence, Players, Genetic, RNA, Awareness, Point, PCR, Lists of diseases, SAN, Coagulation, Danaher Corporation, Internet, Bio-Rad Laboratories, GIA, Molecular diagnostics, Proteomics, Forecasting, DNA, Intelligence, NGS, Research, Biomarker, Pharmaceutical industry, Medical imaging, Pet

SAN FRANCISCO, Oct. 8, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Point of Care (POC) Molecular Diagnostics - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, Oct. 8, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Point of Care (POC) Molecular Diagnostics - Global Market Trajectory & Analytics" .
  • Amid the COVID-19 crisis, the global market for Point of Care (POC) Molecular Diagnostics estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2026, growing at a CAGR of 14.4% over the analysis period.
  • This segment currently accounts for a 19.5% share of the global Point of Care (POC) Molecular Diagnostics market.
  • The U.S. Market is Estimated at $1.1 Billion in 2021, While China is Forecast to Reach $558.7 Million by 2026
    The Point of Care (POC) Molecular Diagnostics market in the U.S. is estimated at US$1.1 Billion in the year 2021.

DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 9, 2021
Research, Medical devices, Genetics, Stem cells, Biotechnology, Other Health, Health, Other Science, Science, Branches of biology, Biology, Life sciences, Biotechnology, Molecular biology, DNA sequencing, DNA, Genetic mapping, Sequencing, Whole genome sequencing, Genetic sequencing

The "DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global DNA sequencing products market reached a value of US$ 5.01 Billion in 2020.
  • Looking forward, the global DNA sequencing products market to exhibit strong growth during the next five years.
  • Global DNA Sequencing Products Market Drivers:
    Genome mapping and sequencing of microorganisms have enabled agriculturists to use them for crops and food plants.

Psomagen, Inc. Expands Precision Genomics Capabilities with 10x Genomics’ Single Cell Sequencing Technologies

Retrieved on: 
Tuesday, February 23, 2021
Branches of biology, Biology, Life sciences, Molecular biology, Biotechnology, DNA sequencing, DNA, Single cell sequencing, Sequencing, Genomics, Genetic sequencing

Rockville, MD, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Psomagen, Inc. , a US-based genetic sequencing and data analysis service provider, is proud to expand its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services .

Key Points: 
  • Rockville, MD, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Psomagen, Inc. , a US-based genetic sequencing and data analysis service provider, is proud to expand its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services .
  • These services, which include gene expression and single cell immune profiling, are powered by the Chromium platform and Next GEM-based technology from 10x Genomics , a life science technology company building products to interrogate, understand, and master biology.
  • Were doing so by mastering laboratory applications such as single cell sequencing and by making such technologies and our expertise accessible and affordable for our clients.
  • Learn more about Psomagens single cell sequencing services and 10x Genomics technology at www.psomagen.com/single-cell-sequencing.

Dante Labs Launches Best Ever Black Friday Offer for Whole Genome

Retrieved on: 
Wednesday, November 25, 2020
Branches of biology, Biology, Genetics, Genomics, Whole genome sequencing, Genome, Genetic testing, Genetic sequencing, Gene sequencing

NEW YORK, Nov. 25, 2020 /PRNewswire/ --Dante Labs announced today its new Black Friday - Cyber Monday offering for Whole Genome Sequencing and reports for 2020.

Key Points: 
  • NEW YORK, Nov. 25, 2020 /PRNewswire/ --Dante Labs announced today its new Black Friday - Cyber Monday offering for Whole Genome Sequencing and reports for 2020.
  • The whole genome sequencing test is the first step toward personalized medicine.
  • Reports are powered by Dante Labs internal software for advanced variant interpretation from whole genome sequencing data.
  • Whole genome sequencing is the analysis of 100% of the DNA, hence the most comprehensive and complete genetic test.

Sequencing Reagents Market: Growth, Trends & Forecast 2020-2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 17, 2020
Health, Genetics, Research, Pharmaceutical, Science, Biotechnology, Branches of biology, Biology, Molecular biology, Biochemistry, Biotechnology, DNA, DNA sequencing, Genetic mapping, In science, Sequencing, Genetic sequencing, Genomics

The "Sequencing Reagents Market: Growth, Trends & Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sequencing Reagents Market: Growth, Trends & Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The Global Sequencing Reagents Market is expected to register a CAGR of 7.5% during the forecast period.
  • In addition, developments in sequencing technologies to provide high yield data for large scale genomic research and availability of new commercial reagents kits for specific sequencing technologies will also promote the growth of the sequencing reagents market.
  • Thus, the declining cost of genetic sequencing will boost the growth sequencing technologies, and which further drive the use of sequencing reagents.

MGI Announces New Advanced Sequencing Chemistry (CoolNGS)

Retrieved on: 
Monday, March 4, 2019
Branches of biology, Biology, Life sciences, Molecular biology, DNA sequencing, Biotechnology, DNA, Whole genome sequencing, BGI Group, Sequencing, Massive parallel sequencing, Genetic sequencing

SAN JOSE, Calif., March 4, 2019 /PRNewswire/ --MGI, a subsidiary of BGI Group, unveiled its novel CoolNGS chemistry, a disruptive new sequencing approach for its DNBseq sequencing technology that enhances the throughput, accuracy, read length and cost effectiveness of DNA sequencing.

Key Points: 
  • SAN JOSE, Calif., March 4, 2019 /PRNewswire/ --MGI, a subsidiary of BGI Group, unveiled its novel CoolNGS chemistry, a disruptive new sequencing approach for its DNBseq sequencing technology that enhances the throughput, accuracy, read length and cost effectiveness of DNA sequencing.
  • A global leader in innovative sequencing platforms, MGI is committed to developing and producing advanced genetic sequencing instruments, consumables and reagents and fostering the industry's progress.
  • The novel proprietary CoolNGS sequencing chemistry announced today avoids DNA "scars" that can accumulate with traditional sequencing methods and affect the accuracy of subsequent reads.
  • MGI is committed to leading the industry into the era of population-scale genome sequencing by providing customers with a unique, scalable sequencing platform.